H Lundbeck

Thursday, 04 November 2021

Latest News for: h. lundbeck

Edit

Lundbeck reports positive results for Vyepti[®] (eptinezumab) from the DELIVER study in patients with migraine and prior preventive treatment failures (H Lundbeck A/S)

Public Technologies 01 Nov 2021

Lundbeck A/S (Lundbeck) announced positive results from the DELIVER study assessing the efficacy and safety of Vyepti® (eptinezumab) 100mg and 300mg IV infusion in patients with chronic or episodic migraine who had experienced two to four previous preventive treatment failures due to lack of efficacy or intolerable side effects.

Edit

Lundbeck receives exclusive rights to APB-A1, an innovative phase I-ready bio-therapeutic for the treatment of neuroimmune diseases from AprilBio (H Lundbeck A/S)

Public Technologies 14 Oct 2021

Lundbeck A/S ... Lundbeck receives exclusive rights to APB-A1, an innovative phase I-ready bio-therapeutic for the treatment of neuroimmune diseases from AprilBio ... Lundbeck A/S (Lundbeck) announced that it has entered into a definitive agreement with AprilBio Co., Ltd ... PALO@lundbeck.com THMR@lundbeck.com ... Lundbeck A/S ... Lundbeck A/S ... info@lundbeck.com.

Edit

Lundbeck receives exclusive rights to APB-A1, an innovative phase I-ready bio-therapeutic for the treatment of neuroimmune diseases from AprilBio

Pharmiweb 14 Oct 2021

Lundbeck A/S (Lundbeck) announced that it has entered into a definitive agreement with AprilBio Co., Ltd ... Johan Luthman, EVP and Head of Research & Development in Lundbeck, said. ... The agreement enables Lundbeck to initiate clinical activities targeting the neuroimmune system ... PALO@lundbeck.com. THMR@lundbeck.com ... Lundbeck A/S ... Lundbeck A/S.

Edit

Otsuka and Lundbeck Announce FDA Acceptance of Supplemental New Drug Application; Receive Priority Review for ...

The Valdosta Daily Times 13 Oct 2021

PRINCETON, N.J. & DEERFIELD, Ill.--(BUSINESS WIRE)--Oct 13, 2021-- ... .

Edit

Danish pharma company Lundbeck downs shutters in India

The Economic Times 06 Oct 2021

The $2.7 billion Lundbeck, which is based out of Bengaluru, has a sales and marketing team of around 100 people in the country ... .

Edit

World Mental Health Day 2021 (H Lundbeck A/S)

Public Technologies 04 Oct 2021

Each year on October 10, Lundbeck and the rest of the world celebrate World Mental Health Day, and this year is no different ... Lundbeck is no exception! We all play a role in this ... Lundbeck A/S published ...

Edit

U.S. court issues decision in Trintellix patent litigation upholding active ingredient patent (H Lundbeck A/S)

Public Technologies 01 Oct 2021

Lundbeck A/S ... Lundbeck A/S (Lundbeck) announces that the U.S. District Court for the District of Delaware (the 'Court') has issued its decision upholding the validity of Lundbeck's patent covering the active ingredient in Trintellix, vortioxetine (U.S ... Lundbeck contacts Investors ... Palo@lundbeck.com thmr@lundbeck.com ... Lundbeck A/S ... Lundbeck A/S.

Edit

A family portrait of the brain (H Lundbeck A/S)

Public Technologies 20 Sep 2021

The miniature microscope and associated data analytics will be used for assessing target engagement, pharmacodynamics, and efficacy of compounds that Lundbeck is developing for the treatment of neurologic and neuropsychiatric disorders.

Edit

Lundbeck continues to deliver solid growth for strategic brands and the financial guidance range has been updated (H Lundbeck A/S)

Public Technologies 18 Aug 2021

Lundbeck A/S ... Lundbeck continues to deliver solid growth for strategic brands and the financial guidance range has been updated ... In connection with the financial report, Lundbeck's President and CEO Deborah Dunsire said. ... Lundbeck now expects revenue to reach DKK 16.3 - 16.6 billion ... Lundbeck A/S ... info@lundbeck.com.

Edit

Down Syndrome Market Latest Innovation, Advance Technology And Top Companies OPKO Health, Inc., LuMind IDSC Foundation, MIT Alana Center, H. Lundbeck A/S, AC Immune

Pharmiweb 12 Aug 2021

Lundbeck A/S, AC Immune, Advocate Health Care, Inc., Annovis Bio, Inc., ManRos Therapeutics, Pfizer Inc., Eisai Co., Ltd., Balance Therapeutics, Bayer AG, Genentech, Inc., Promega Corporation, Johnson & Johnson Services, Inc., Lonza, ALLERGAN, Cognition Therapeutics, Inc., ...

Edit

Lundbeck enters strategic research collaboration with Rgenta Therapeutics on therapies targeting RNA (H Lundbeck A/S)

Public Technologies 04 Aug 2021

Lundbeck is entering a new strategic partnership with Rgenta Therapeutics to further enhance the research efforts to develop treatments for brain diseases ... Lundbeck holds the opportunity to exclusively license potential drug candidates for further development and commercialization ... A possibility for Lundbeck.

Edit

Rgenta Therapeutics Enters into a Collaboration with Lundbeck

PR Newswire 04 Aug 2021

Lundbeck A/S aimed at the discovery of small molecules targeting RNA regulation and splicing of disease-causing genes for neurological disorders ... Rgenta will grant Lundbeck the option to exclusively license the candidate molecules, which will be developed and commercialized by Lundbeck.

Edit

This is a new feature (H Lundbeck A/S)

Public Technologies 30 Jul 2021

Lundbeck A/S published this content on 31 July 2021 and is solely ...

Edit

What do you mean brain health? (H Lundbeck A/S)

Public Technologies 22 Jul 2021

World Health Organization ... Prevention is. therefore to brain health, what treatment and rehabilitation are to brain disease ... Persistence ... Lundbeck's #1VoiceSummit is an annual event gathering advocacy groups passionate about brain health ... Lundbeck A/S published this content on 22 July 2021 and is solely responsible for the information contained therein.

Edit

Denovo Biopharma In-Licenses Late-Stage Alzheimer's Disease Asset from Lundbeck

PR Newswire 01 Jul 2021

Lundbeck A/S, including all rights to develop, manufacture and commercialize idalopirdine for all indications. Lundbeck received options to re-acquire idalopirdine for predetermined undisclosed financial terms, with Denovo and Lundbeck sharing China rights in the event Lundbeck's ...